Immucell Corp (ICCC) is a publicly traded Healthcare sector company. As of May 21, 2026, ICCC trades at $9.88 with a market cap of $89.65M and a P/E ratio of -140.91. ICCC moved -4.90% today. Year to date, ICCC is +63.31%; over the trailing twelve months it is +78.34%. Its 52-week range spans $3.38 to $10.25. Rallies surfaces ICCC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the latest ICCC stock research?
Immucell Corp (ICCC) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ICCC moved -4.90% today.
te Boekhorst Paul Francis Olivier bought 2.43K (~$13.38K) on Dec 4, 2025.
te Boekhorst Paul Francis Olivier bought 3.60K (~$18.15K) on Dec 3, 2025.
te Boekhorst Paul Francis Olivier bought 2.56K (~$12.79K) on Dec 3, 2025.
ICCC Analyst Consensus
ICCC analyst coverage data. Average price target: $0.00.
Common questions about ICCC
What can I research for ICCC on Rallies?
Immucell Corp (ICCC) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ICCC moved -4.90% today.
Does Rallies show live market data for ICCC?
Rallies combines live market context with ticker research for ICCC, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
